Finance

Lists
SVA:TSE
Sernova Biotherapeutics Inc
CA$0.12
0.00%
(0.00) 1D
Oct 9, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for SVA...
Open
CA$0.12
High
CA$0.12
Low
CA$0.12
Mkt. cap
41.53M
Avg. vol.
353.07K
Volume
16.36K
52-wk high
CA$0.20
52-wk low
CA$0.08
EPS
-CA$0.03
Beta
32.05
Shares outstanding
377.64M
No. of employees
8
Open
CA$0.12
High
CA$0.12
Low
CA$0.12
Mkt. cap
41.53M
Avg. vol.
353.07K
Volume
16.36K
52-wk high
CA$0.20
52-wk low
CA$0.08
EPS
-CA$0.03
Beta
32.05
Shares outstanding
377.64M
No. of employees
8
News stories
From web sources and news partners
About Sernova Biotherapeutics Inc
CEOJonathan Rigby
Employees8
Founded2006
HeadquartersLondon, Ontario, Canada
SectorBiotechnology
Websitesernova.com
Last report
Sep 10, 2026
Fiscal period
Q3 2026
-CA$0.01 / -CA$0.00
-100.00%miss
Revenue / Est. (CAD)
- / 0.00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps